[Short-term study of proglumetacin].
Twenty-five patients with joint rheumatoid pain were treated as outpatients during 15 days with 450 mg/day fo proglumetacin. Efficacy was "good" or "very good" in 64% of the patients. No case of clinically significant side-effects was observed.
D000328:Adult; D000368:Aged; D001416:Back Pain / Q000188:drug therapy; D020968:Brachial Plexus Neuritis / Q000188:drug therapy; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007210:Indoleacetic Acids / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy; D052256:Tendinopathy / Q000188:drug therapy
D007210:Indoleacetic Acids; C019541:proglumetacin
Studio a breve termine della proglumetacina.